In the absence of funding to begin or continue crucial medical and scientific research, the pipeline of domestic and international talent will begin drying up—and it will occur at the exact moment that China is striving to become a biomedical and biopharmaceutical superpower. But the termination had nothing to do with that; rather, Fodera says the note she received from the NIH said the reason was “unsafe antisemitic actions that suggest the institution lacks concern for the safety and well-being of Jewish students.” “The slashing of positions at CDC, at FDA--there's nothing about it that seems like it is based on a strategic approach to maintaining and improving the health of people in America and around the world,” says Richard Besser, former acting director of the CDC, who since 2017 has served as president and CEO of the Robert Woods Johnson Foundation .
Author: Carolyn Barber
Published at: 2025-04-13 22:40:07
Still want to read the full version? Full article
